文献速递外周血管介入儿科影像DSAUS

儿童症状性闭塞性疾病的 下肢 静脉内重建:技术、临床结局与长期支架通畅率

Lower extremity endovenous reconstruction for symptomatic occlusive disease in pediatric patients: techniques, clinical outcomes, and long-term stent patencies.
PubMed 文献 · Pediatr Radiol · 2019-03-09

14例儿童慢性髂腔静脉血栓患者接受髂腔静脉支架重建,技术成功率100%,仅2例轻微不良事件;2周、6个月、12个月临床成功率分别为85%、82%、83%,末次随访平均88个月时临床成功率93%;估算6个月和12个月原发支架通畅率分别为86%和64%,6个月和12个月原发辅助及继发通畅率均为100%。

要点

  • 儿童慢性髂腔静脉血栓行支架重建技术成功率100%,仅2例(14%)轻微不良事件。
  • 12个月原发支架通畅率64%,但原发辅助和继发通畅率均达100%。
  • 平均随访88个月时临床成功率93%,CEAP评分较基线下降≥1分。

核心结论

  • 髂腔静脉支架重建对儿童症状性慢性髂腔静脉血栓是有效治疗,技术成功率高,6个月和12个月临床成功率及原发辅助、继发通畅率均高。

研究设计与样本

  • 单中心回顾性研究,纳入14例儿童慢性髂腔静脉血栓患者(13例男性,平均年龄16.4岁,范围8-20岁),行髂腔静脉支架重建,记录再通与重建方式、支架技术成功、并发症、临床结局及支架通畅率;临床成功定义为CEAP评分下降1分,通畅率按欧洲心血管与介入放射学会指南定义。

诊断标准与关键数值

  • 临床成功定义为CEAP评分下降1分。
  • 原发、原发辅助和继发通畅率按欧洲心血管与介入放射学会指南定义。
  • 支架技术成功率为100%。
  • 2周、6个月和12个月临床成功率分别为85%、82%和83%;末次平均随访88个月(范围16-231个月)时临床成功率为93%。
  • 估算6个月和12个月原发支架通畅率分别为86%和64%;6个月和12个月原发辅助及继发支架通畅率均为100%。

临床应用与阅片要点

  • 本组多数手术采用3个入路部位(范围2-4个),11例(79%)手术使用血管内超声。
  • 12例(86%)采用钝性再通技术,2例(14%)采用锐性再通技术。
  • 术后平均住院2.8天(范围1-8天)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Endovascular stent reconstruction is the standard of care for chronic venous occlusive disease in adults, but it has not been reported in pediatric patients.

OBJECTIVE: This study reports the technical success, complications, clinical outcomes, and stent patency of iliocaval stent reconstruction for chronic iliocaval thrombosis in pediatric patients.

MATERIALS AND METHODS: Fourteen patients, 13 (93%) male with a mean age of 16.4 years (range: 8-20 years), underwent iliocaval stent reconstruction for chronic iliocaval thrombosis. The mean number of prothrombotic risk factors was 2.5 (range: 0-4), including 7 (50%) patients with inferior vena cava atresia. At initial presentation, the Clinical, Etiology, Anatomy, and Pathophysiology classification (CEAP) score was C3 in 2 (14%) patients, C4 in 11 (79%) patients, and C6 in 1 (7.1%) patient. Time course of presenting symptoms included chronic (>4 weeks) (n=7; 50%) and acute worsening of chronic symptoms (2-4 weeks) (n=7; 50%). Aspects of recanalization and reconstruction, stenting technical success, complications, clinical outcomes and stent patency were recorded. Clinical success was defined as a 1-point decrease in the CEAP. Primary, primary-assisted, and secondary patency were defined by Cardiovascular and Interventional Radiological Society of Europe guidelines.

RESULTS: Most procedures employed three access sites (range: 2-4). Intravascular ultrasound was employed in 11 (79%) procedures. Blunt and sharp recanalization techniques were used in 12 (86%) and 2 (14%) patients, respectively. Stenting technical success was 100%. Two (14%) minor adverse events occurred and mean post-procedure hospitalization was 2.8 days (range: 1-8 days). Clinical success rates at 2 weeks, 6 months and 12 months were 85%, 82%, and 83%, respectively. At a mean final clinical follow-up of 88 months (range: 16-231 months), clinical success was 93%. Estimated 6- and 12-month primary stent patencies were 86% and 64%, respectively. Six- and 12-month primary-assisted and secondary stent patency rates were both 100%.

CONCLUSION: Iliocaval stent reconstruction is an effective treatment for symptomatic chronic iliocaval thrombosis in pediatric patients with high rates of technical success, 6- and 12-month clinical success, and 6- and 12-month primary-assisted and secondary patency rates.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. McDevitt JL, Srinivasa RN, Hage AN, et al. Lower extremity endovenous reconstruction for symptomatic occlusive disease in pediatric patients: techniques, clinical outcomes, and long-term stent patencies. Pediatr Radiol. 2019. PMID: 30852651. doi:10.1007/s00247-019-04357-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。